Fatal herpetic hepatitis in adult following short corticotherapy: a case report. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Fatal herpetic hepatitis in adult following short corticotherapy: a case report.

Intensive Care Med. 1999 Apr;25(4):415-7. Unique Identifier : AIDSLINE MED/99271947
Seksik P; Gozlan J; Guitton C; Galula G; Maury E; Offenstadt G; Medical Intensive Care Unit, Hopital Saint-Antoine, Assistance; Publique-Hopitaux de Paris, France.

Abstract: Herpes simplex virus hepatitis (HSV hepatitis) is an uncommon and severe complication of HSV type 1 and HSV type 2 infection. HSV hepatitis affects mostly immunocompromised patients. We report the case of a young man without any previous known immunodeficiency who developed fatal HSV hepatitis in the first 8 days of oral corticotherapy given for ulcerative colitis. A prompt diagnosis was possible because HSV was recovered from peripheral blood leukocytes.
Keywords: JOURNAL ARTICLE Acute Disease Adult Anti-Inflammatory Agents, Steroidal/*THERAPEUTIC USE Case Report Colitis, Ulcerative/*DRUG THERAPY Diagnosis, Differential Fatal Outcome Hepatitis, Viral, Human/*DIAGNOSIS Herpes Simplex/*DIAGNOSIS Herpesvirus 1, Human/ISOLATION & PURIF Herpesvirus 2, Human/ISOLATION & PURIF Human Male Prednisone/*THERAPEUTIC USEKWDjournalarticleacutediseaseadultanti-inflammatoryagents,steroidal/KWDtherapeuticusecasereportcolitis,ulcerative/KWDdrugtherapydiagnosis,differentialfataloutcomehepatitis,viral,human/KWDdiagnosisherpessimplex/KWDdiagnosisherpesvirus1,human/isolation&purifherpesvirus2,human/isolation&purifhumanmaleprednisone/KWDtherapeuticuse
991030
A99A0877

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .